Sanofi recalls vaccine; BMS get EU approval for Orencia;

@FiercePharma: Takeda continues buying spree, picks up LigoCyte. More | Follow @FiercePharma

@EricPFierce: Australia Mayne Pharma buying SC-based CDMO Metrics for $105 million plus milestone. More | Follow @EricPFierce

> Sanofi Pasteur is recalling several batches of its typhoid fever vaccine saying they may not reach potency specifications. Story

> A study suggests a single injection of Allergan's ($AGN) Botox can help reduce urinary incontinence as effectively as daily drugs, perhaps setting the cosmetic drug up for a new use. Story

> Bristol-Myers Squibb ($BMY) says the European Commission has approved its subcutaneous formulation of Orencia for treatment of moderate to severe rheumatoid arthritis (RA). Item

> GlaxoSmithKline ($GSK) has officially ended its development of an experimental antibiotic after halting enrollment in trials for the candidate early this year, handing back the asset to Anacor Pharmaceuticals ($ANAC). Story

>The FTC is asking the Supreme Court to review lower court decisions saying that when Solvay Pharmaceuticals settled with generic drugmakers over its testosterone treatment, they were not anti-competitive. Story 

Biotech News

 @FierceBiotech: Sanofi stands up for diabetes therapy in crowded GLP-1 contest. More | Follow @FierceBiotech

 @JohnCFierce: Anacor gets an antibiotic back from Glaxo after microbiological resistance was seen in a study. Worthless now. More | Follow @JohnCFierce

 @RyanMFierce: Takeda builds up new vaccine unit with $60M LigoCyte buyout, with interview quotes. Article | Follow @RyanMFierce

> Defining 'fierce' in the modern age of drug and device development. Editor's Corner

> The Medicines Co. abandons blood-loss drug over safety risk. More

Medical Device News

 @FierceMedDev: Renal denervation's not just for hypertension--docs say it could help diabetics, too. More | Follow @FierceMedDev

 @MarkHFierce: Ilex will sell Novartis' blood test Dx kits in 16 African countries. More | Follow @MarkHFierce

 @DamianFierce: According to a new study, women fare worse with stents than men. More | Follow @DamianFierce

> Given Imaging grabs SmartPill Corp. for $6M. Story

> New math models aid artifical pancreas development. Item

And Finally... The outbreak of meningitis, tied to a drug made by a pharmacy compounder, is raising questions about whether compounders need to be better regulated. Story

Suggested Articles

Three Samsung execs face up to two years in jail for their roles in destroying data and documents at under-fire affiliate Samsung BioLogics.

The FDA has slapped a U.S. drug repackager, saying in a warning letter that its storage processes and equipment cleaning are not up to expectations.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.